These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 4636388)

  • 1. Effect of spironolactone, pregnenolone-16 -carbonitrile and cortisol on the metabolism and biliary excretion of sulfobromophthalein and phenol-3,6-dibromophthalein disulfonate in rats.
    Zsigmond G; Solymoss B
    J Pharmacol Exp Ther; 1972 Dec; 183(3):499-507. PubMed ID: 4636388
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma disappearance and biliary excretion of sulfobromophthalein and phenol-3,6-dibromphthalein disulfonate after microsomal enzyme induction.
    Klaassen CD
    Biochem Pharmacol; 1970 Apr; 19(4):1241-9. PubMed ID: 4398009
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of combined treatment with pregnenolone-16alpha-carbonitrile and spironolactone or phenobarbital on drug metabolism in rats.
    Ship S; Kourounakis P
    Biochem Pharmacol; 1977 Mar; 26(6):467-72. PubMed ID: 849342
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cycloheximide on the ultrastructural changes produced by spironolactone and pregnenolone-16 alpha-carbonitrile in the rat liver.
    Khandekar JD; Garg BD; Dardachti D; Tuchweber B; Kovacs K
    Beitr Pathol; 1971 Aug; 144(1):33-43. PubMed ID: 4399449
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of dactinomycin on the ultrastructural changes induced in rat hepatocytes by spironolactone and pregnelonone-16 -carbonitrile.
    Garg BD; Khandekar JD; Tuchweber B; Kovacs K
    Agressologie; 1971; 12(2):119-26. PubMed ID: 5123845
    [No Abstract]   [Full Text] [Related]  

  • 6. Biliary excretion of sulfobromophthalein in isolated perfused livers from normal and spironolactone-treated rats.
    Pellegrino JM; Mottino AD; Rodriguez JV; Rodriguez Garay EA
    Experientia; 1982 Jan; 38(1):112-4. PubMed ID: 7056350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of spironolactone and pregnenolone-16alpha carbonitrile on bilirubin metabolism and plasma levels in male and female rats.
    Radzialowski FM
    Biochem Pharmacol; 1973 Jul; 22(13):1607-11. PubMed ID: 4729808
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations in the hepatic subcellular composition of nucleic acids and proteins in rats treated with pregnenolone-16alpha-carbonitrile, spironolactone or phenobarbital.
    Lykissas ED; Kourounakis P; Da Silva OM
    Acta Hepatogastroenterol (Stuttg); 1979 Aug; 26(4):290-5. PubMed ID: 495026
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenobarbital-enhanced biliary excretion of administered unconjugated and conjugated sulfobromophthalein (BSP) in the rat.
    Whelan G; Combes B
    Biochem Pharmacol; 1975 Jul; 24(13-14):1283-6. PubMed ID: 1148017
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of various steroids on the hepatic glucuronidation and biliary excretion of bilirubin.
    Solymoss B; Zsigmond G
    Can J Physiol Pharmacol; 1973 May; 51(5):319-23. PubMed ID: 4746700
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of phenobarbital, spironolactone and pregnenolone-16 alpha-carbonitrile on bile formation in the rat.
    von Bergmann K; Schwarz HP; Paumgartner G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287(1):33-45. PubMed ID: 1118040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phenobarbital, spironolactone and pregnenolone-16 alpha-carbonitrile on rat hepatic beta-glucuronidase.
    Kourounakis PN; Tani E
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):119-22. PubMed ID: 7620833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pregnenolone-16alpha-carbonitrile and nephrectomy on the rat liver.
    Garg BD; Szabo S; Tuchweber B; Kovacs K
    Exp Pathol (Jena); 1974; 9(3):175-81. PubMed ID: 4435092
    [No Abstract]   [Full Text] [Related]  

  • 14. Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
    Gregus Z; Watkins JB; Thompson TN; Klaassen CD
    J Pharmacol Exp Ther; 1983 May; 225(2):256-62. PubMed ID: 6405026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic disposition of phenoldibromphthalein disulfonate and sulfobromophthalein.
    Klaassen CD; Plaa G
    Am J Physiol; 1968 Oct; 215(4):971-6. PubMed ID: 5676401
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of phenobarbitone on the biliary reabsorption of [35S] sulpho-bromophthalein sodium from the rat biliary tree.
    Dammann HG
    J Pharm Pharmacol; 1978 Jun; 30(6):381-2. PubMed ID: 26773
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of microsomal enzyme inducers on the biliary excretion of cardiac glycosides.
    Klaassen CD
    J Pharmacol Exp Ther; 1974 Nov; 191(2):201-11. PubMed ID: 4418514
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection by catatoxic steroids, phenobarbital and diphenylhydantoin against methaqualone intoxication.
    Selye H; Szabo S; Kourounakis P
    Steroids Lipids Res; 1972; 3(2):156-9. PubMed ID: 4657990
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of phenobarbital and steroids on phalloidin toxicity in rats.
    Tuchweber B; Kovacs K; Khandekar JD; Garg BD
    Toxicon; 1972 Jun; 10(4):357-61. PubMed ID: 5070574
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of pregnenolone-16 -carbonitrile on hepatic mixed-function oxygenases.
    Solymoss B; Werringloer J; Toth S
    Steroids; 1971 Apr; 17(4):427-33. PubMed ID: 4400159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.